Nathan Rice – Goldman Sachs

Goldman Sachs

A Goldman Sachs analyst with 5 tracked ratings across 5 distinct tickers has issued 3 hold ratings and maintains a 0% success rate on the captured sample, focusing on a single source category.

Aggregated from multiple market-data sources

Total ratings

Tickers covered

Sources

Aggregated

Latest rating

2 years ago

2023-12-11 00:00:00+00

Track record

Aggregated

0% success rate

Bullish: 0
Hold: 6
Bearish: 2

Aggregated

Not available

Recent ratings

Ticker	Date	Rating	Price target	Source
ALGN	2023-12-11	sell	$197.00	Aggregated
ALGNALIGN TECHNOLOGY, INC.	2023-12-11	unknown	$197.00	Aggregated
ELAN	2023-04-25	sell	$9.00	Aggregated
ELANELANCO ANIMAL HEALTH INC	2023-04-25	unknown	$9.00	Aggregated
CI	2021-12-14	hold	$233.00	Aggregated
CICIGNA GROUP (THE)	2021-12-14	hold	$233.00	Aggregated
CNC	2021-12-14	hold	$83.00	Aggregated
CNCCENTENE CORP.	2021-12-14	hold	$83.00	Aggregated
IDXX	2021-08-03	hold	$610.00	Aggregated
IDXXIDEXX LABORATORIES, INC.	2021-08-03	hold	$610.00	Aggregated

Tickers covered(10)

Ticker	Ratings	Last rating	Sources
ALGN	2	2023-12-11	Aggregated
ALGNALIGN TECHNOLOGY, INC.	1	2023-12-11	Aggregated
ELAN	2	2023-04-25	Aggregated
ELANELANCO ANIMAL HEALTH INC	1	2023-04-25	Aggregated
CI	1	2021-12-14	Aggregated
CICIGNA GROUP (THE)	1	2021-12-14	Aggregated
CNC	1	2021-12-14	Aggregated
CNCCENTENE CORP.	1	2021-12-14	Aggregated
IDXX	1	2021-08-03	Aggregated
IDXXIDEXX LABORATORIES, INC.	1	2021-08-03	Aggregated

Methodology differs by source. Track records are aggregated from multiple sources; scoring methodology and scales differ by source and values are not directly comparable. Coverage is sourced from publicly-aggregated analyst activity. Past performance does not guarantee future results. Not investment advice.